Topics

. He can be reached at nsaraceno@mjhlifesciences.com.

Articles

The partnership creates an integrated solution that also tackles compliance challenges within the sector. 

LSPedia, Pharma Logistics Strike Up Supply Chain Visibility Collaboration

A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.

An Examination of Big Pharma Inventories

The collaboration—which is now active until 2031, features a $25 million payment to Evotec for progress made in neurodegenerative disease research.

Evotec-Bristol Myers Squibb Partnership Further Develops as Pipeline Expands

Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.

Who Moved My Prescription? Part V: The Many Layers of Pharmacy Crisis Point

Balancing innovation focus with optimized decision-making.


Biotech’s Achilles’ Heel

ROCTAVIAN will only be sold to the United States, Italian, and German markets, as the company eyes its profitability by 2025. 

BioMarin Adjusts Sales Plan for Severe Hemophilia A Gene Therapy

Per the deal, DKSH inherits the specialty pharma company’s Asia-Pacific medication portfolio. 

DKSH, Kyowa Kirin Sign Strategic Partnership 

In deal that has the potential to reach $1.1 billion, Otsuka aims to grow its drug pipeline, specifically in the field of rare and autoimmune diseases. 

Otsuka Pharmaceutical to Purchase Jnana Therapeutics 

The parties’ combined portfolio help tackle the rising demand for advanced cell and gene therapies.  

MilliporeSigma Finalizes Mirus Bio Deal

Gallagher’s 2024 US Physical & Emotional Wellbeing Report outlines ways to meeting evolving needs in the workforce. 

Business and Finance